Forte Biosciences (FBRX) Interest & Investment Income (2016 - 2020)
Forte Biosciences (FBRX) posted quarterly Interest & Investment Income of $58000.0 for Q1 2020, down 89.28% year-over-year from $541000.0 in Q2 2019, and down 70.56% quarter-over-quarter from $197000.0 in Q4 2019.
Powered by 
Analysis
Forte Biosciences (FBRX) Interest & Investment Income (2016 - 2020) Analysis & Trends
Forte Biosciences (FBRX) has reported Interest & Investment Income for 5 consecutive years, with $58000.0 the latest figure, recorded in Q1 2020.
- In Q1 2020, Interest & Investment Income fell 89.28% year-over-year to $58000.0; the TTM figure through Mar 2020 stood at $1.1 million (down 38.58% YoY), while the FY2019 annual figure was $1.6 million, up 1.96% from the prior year.
- Interest & Investment Income eased to $58000.0 in Q1 2020 per FBRX's latest filing, from $197000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $541000.0 in Q1 2019 and bottomed at $37000.0 in Q1 2017.
- Historically, Interest & Investment Income has averaged $233294.1 across 5 years, with a median of $214000.0 in 2017.
- Annual changes were most pronounced in 2018 — Interest & Investment Income surged 751.35% — and 2020, when it tumbled 89.28%.
- Forte Biosciences' Interest & Investment Income stood at $45000.0 in 2016, then jumped by 435.56% to $241000.0 in 2017, then jumped by 85.48% to $447000.0 in 2018, then sank by 55.93% to $197000.0 in 2019, then tumbled by 70.56% to $58000.0 in 2020.
- Business Quant data shows FBRX's Interest & Investment Income at $58000.0 in Q1 2020, $197000.0 in Q4 2019, and $361000.0 in Q3 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Forte Biosciences | 1.58 Bn | 1.23 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2020 | 58,000.00 |
| Dec 31, 2019 | 197,000.00 |
| Sep 30, 2019 | 361,000.00 |
| Jun 30, 2019 | 465,000.00 |
| Mar 31, 2019 | 541,000.00 |
| Dec 31, 2018 | 447,000.00 |
| Sep 30, 2018 | 441,000.00 |
| Jun 30, 2018 | 331,000.00 |
| Mar 31, 2018 | 315,000.00 |
| Dec 31, 2017 | 241,000.00 |
| Sep 30, 2017 | 214,000.00 |
| Jun 30, 2017 | 103,000.00 |
| Mar 31, 2017 | 37,000.00 |
| Dec 31, 2016 | 45,000.00 |
| Sep 30, 2016 | 53,000.00 |
| Jun 30, 2016 | 56,000.00 |
| Mar 31, 2016 | 61,000.00 |